Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 820

1.

Call-out culture demands perfection from everyone except oneself.

Sundar S.

BMJ. 2020 Jan 20;368:m158. doi: 10.1136/bmj.m158. No abstract available.

PMID:
31959696
2.

Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?

Kumar S, Srinivasan A, Phillips A, Madhupriya R, Pascoe J, Nevin J, Elattar A, Balega J, Cummins C, Sundar S, Kehoe ST, Singh K.

J Obstet Gynaecol. 2020 Jan 14:1-7. doi: 10.1080/01443615.2019.1674264. [Epub ahead of print]

PMID:
31933417
3.

Cardiomyopathy Mutation Alters End-to-End Junction of Tropomyosin and Reduces Calcium Sensitivity.

Sundar S, Rynkiewicz MJ, Ghosh A, Lehman W, Moore JR.

Biophys J. 2020 Jan 21;118(2):303-312. doi: 10.1016/j.bpj.2019.11.3396. Epub 2019 Dec 14.

PMID:
31882250
4.

Comments on: Bringing OSCEs into the 21st century.

Sundar S.

Med Teach. 2019 Dec 27:1. doi: 10.1080/0142159X.2019.1706727. [Epub ahead of print] No abstract available.

PMID:
31880196
5.

Setting Our Sights on Infectious Diseases.

De Rycker M, Horn D, Aldridge B, Amewu RK, Barry CE 3rd, Buckner FS, Cook S, Ferguson MAJ, Gobeau N, Herrmann J, Herrling P, Hope W, Keiser J, Lafuente-Monasterio MJ, Leeson PD, Leroy D, Manjunatha UH, McCarthy J, Miles TJ, Mizrahi V, Moshynets O, Niles J, Overington JP, Pottage J, Rao SPS, Read KD, Ribeiro I, Silver LL, Southern J, Spangenberg T, Sundar S, Taylor C, Van Voorhis W, White NJ, Wyllie S, Wyatt PG, Gilbert IH.

ACS Infect Dis. 2020 Jan 10;6(1):3-13. doi: 10.1021/acsinfecdis.9b00371. Epub 2019 Dec 6.

6.

Prognosis of early stage small cell bladder cancer is not always dismal.

Lim JH, Sundar S.

ESMO Open. 2019 Nov 13;4(6):e000559. doi: 10.1136/esmoopen-2019-000559. eCollection 2019.

7.

Treating sepsis in dying patients is futile.

Sundar S.

BMJ. 2019 Dec 2;367:l6706. doi: 10.1136/bmj.l6706. No abstract available.

PMID:
31792100
8.

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.

Clamp AR, James EC, McNeish IA, Dean A, Kim JW, O'Donnell DM, Hook J, Coyle C, Blagden S, Brenton JD, Naik R, Perren T, Sundar S, Cook AD, Gopalakrishnan GS, Gabra H, Lord R, Dark G, Earl HM, Hall M, Banerjee S, Glasspool RM, Jones R, Williams S, Swart AM, Stenning S, Parmar M, Kaplan R, Ledermann JA.

Lancet. 2019 Dec 7;394(10214):2084-2095. doi: 10.1016/S0140-6736(19)32259-7. Epub 2019 Nov 29.

9.

Observation of Single Nanoparticle Collisions with Green Synthesized Pt, Au, and Ag Nanoparticles Using Electrocatalytic Signal Amplification Method.

Sundar S, Kim KJ, Kwon SJ.

Nanomaterials (Basel). 2019 Nov 27;9(12). pii: E1695. doi: 10.3390/nano9121695.

10.

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.

Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Bedke J, Gakis G, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Garcia Del Muro X, Rodriguez-Vida A, Cicin I, Harputluoglu H, Tagawa ST, Vaishampayan U, Aragon-Ching JB, Hamid O, Liepa AM, Wijayawardana S, Russo F, Walgren RA, Zimmermann AH, Hozak RR, Bell-McGuinn KM, Powles T; RANGE study investigators.

Lancet Oncol. 2020 Jan;21(1):105-120. doi: 10.1016/S1470-2045(19)30668-0. Epub 2019 Nov 18.

PMID:
31753727
11.

Comment on "The Impact of Preoperative Immune Modulating Nutrition on Outcomes in Patients Undergoing Surgery for Gastrointestinal Cancer".

Knight SR, Burden S, Sundar S, Harrison EM.

Ann Surg. 2019 Dec;270(6):e127-e128. doi: 10.1097/SLA.0000000000003345. No abstract available.

PMID:
31726643
12.

Sub-Acute more than Chronic Hyponatremia is associated with Serious Falls and Hip Fractures.

Bhandari SK, Adams AL, Li BH, Rhee CM, Sundar S, Krasa H, Danforth KN, Kanter MH, Kalantar-Zadeh K, Jacobsen SJ, Sim JJ.

Intern Med J. 2019 Nov 10. doi: 10.1111/imj.14684. [Epub ahead of print]

PMID:
31707754
13.

Sentinel lymph node consensus document of the British Gynaecological Cancer Society for endometrial, vulvar, and cervical cancers.

Fotopoulou C, Ind T, Baldwin P, Crawford R, Devaja O, Dobbs S, Frost J, Gajjar K, Ganesan R, Kaushik S, Morrison J, Nobbenhuis M, Ratnavelu N, Rolland P, Singh N, Taylor A, Sundar S, Nordin A.

Int J Gynecol Cancer. 2019 Nov;29(9):1348-1350. doi: 10.1136/ijgc-2019-000798. No abstract available.

PMID:
31685556
14.

Post kala azar dermal leishmaniasis and leprosy prevalence and distribution in the Muzaffarpur health and demographic surveillance site.

Hasker E, Malaviya P, Scholar VK, de Koning P, Singh OP, Kansal S, Cloots K, Boelaert M, Sundar S.

PLoS Negl Trop Dis. 2019 Oct 25;13(10):e0007798. doi: 10.1371/journal.pntd.0007798. eCollection 2019 Oct.

15.

Investigation of anti-inflammatory and anti-cancer activity of Justicia adathoda metabolites.

Sudevan S, Parasivam R, Sundar S, Velauthan H, Ramasamy V.

Pak J Pharm Sci. 2019 Jul;32(4):1555-1561.

PMID:
31608874
16.

Rv0807, a putative phospholipase A2 of Mycobacterium tuberculosis; Elucidation through sequence analysis, homology modeling, molecular docking and molecular dynamics studies of potential substrates and inhibitors.

Sundar S, Thangamani L, Manivel G, Kumar P, Piramanayagam S.

J Biomol Struct Dyn. 2019 Oct 24:1-15. doi: 10.1080/07391102.2019.1677499. [Epub ahead of print]

PMID:
31588859
17.

Outcome of HIV Related Kidney Diseases Treated with Combined Antiretroviral Therapy (cART).

Prakash J, Iqbal M, Patel PS, Prakash S, Sundar S, Singh U.

J Assoc Physicians India. 2019 Sep;67(9):18-22.

PMID:
31561682
18.

A Rare Nonvenereal Presentation of Oral Condyloma Acuminatum.

Sudhakar S, Senthil B, Sundar S.

Indian J Dermatol. 2019 Sep-Oct;64(5):419-420. doi: 10.4103/ijd.IJD_543_18. No abstract available.

19.

A molecular signature for CD8+ T cells from visceral leishmaniasis patients.

Singh B, Bhushan Chauhan S, Kumar R, Singh SS, Ng S, Amante F, de Labastida Rivera F, Singh OP, Rai M, Nylen S, Sundar S, Engwerda C.

Parasite Immunol. 2019 Nov;41(11):e12669. doi: 10.1111/pim.12669. Epub 2019 Sep 30.

PMID:
31494954
20.

Magneto-Biosensor for the Detection of Uric Acid Using Citric Acid-Capped Iron Oxide Nanoparticles.

Sundar S, Kwon SJ, Venkatachalam G.

J Nanosci Nanotechnol. 2020 Apr 1;20(4):2144-2153. doi: 10.1166/jnn.2020.17313.

PMID:
31492223
21.

Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India.

Lappan R, Classon C, Kumar S, Singh OP, de Almeida RV, Chakravarty J, Kumari P, Kansal S, Sundar S, Blackwell JM.

PLoS Negl Trop Dis. 2019 Sep 6;13(9):e0007444. doi: 10.1371/journal.pntd.0007444. eCollection 2019 Sep.

22.

Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar.

Sundar S, Singh A, Agrawal N, Chakravarty J.

Am J Trop Med Hyg. 2019 Oct;101(4):795-798. doi: 10.4269/ajtmh.19-0179.

PMID:
31436156
23.

Late cancer diagnoses: biology triumphs clinical acumen.

Sundar S.

BMJ. 2019 Aug 18;366:l5155. doi: 10.1136/bmj.l5155. No abstract available.

PMID:
31427283
24.

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India.

Fakiola M, Singh OP, Syn G, Singh T, Singh B, Chakravarty J, Sundar S, Blackwell JM.

PLoS Negl Trop Dis. 2019 Aug 16;13(8):e0007673. doi: 10.1371/journal.pntd.0007673. eCollection 2019 Aug.

25.

Socioeconomic differences impact overall survival in advanced ovarian cancer (AOC) prior to achievement of standard therapy.

Phillips A, Kehoe S, Singh K, Elattar A, Nevin J, Balega J, Pounds R, Elmodir A, Pascoe J, Fernando I, Sundar S.

Arch Gynecol Obstet. 2019 Nov;300(5):1261-1270. doi: 10.1007/s00404-019-05269-8. Epub 2019 Aug 14.

PMID:
31414175
26.

Costs associated with unplanned readmissions among patients with heart failure with and without hyponatremia.

Amin AN, Ortendahl JD, Harmon AL, Kamat SA, Stellhorn RA, Chase SL, Sundar SV.

Am J Health Syst Pharm. 2019 Feb 21;76(6):374-380. doi: 10.1093/ajhp/zxy064.

PMID:
31361839
27.

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.

Gentry-Maharaj A, Burnell M, Dilley J, Ryan A, Karpinskyj C, Gunu R, Mallett S, Deeks J, Campbell S, Jacobs I, Sundar S, Menon U.

Am J Obstet Gynecol. 2020 Jan;222(1):56.e1-56.e17. doi: 10.1016/j.ajog.2019.07.031. Epub 2019 Jul 24.

28.

Cost and quality of life outcome analysis of postoperative infections after posterior lumbar decompression and fusion.

Pennington Z, Sundar SJ, Lubelski D, Alvin MD, Benzel EC, Mroz TE.

J Clin Neurosci. 2019 Oct;68:105-110. doi: 10.1016/j.jocn.2019.07.025. Epub 2019 Jul 23.

PMID:
31350079
29.

Plasma-grain interaction mediated by streaming non-Maxwellian ions.

Sundar S, Moldabekov ZA.

Phys Rev E. 2019 Jun;99(6-1):063202. doi: 10.1103/PhysRevE.99.063202.

PMID:
31330743
30.

Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application.

Singh OP, Gedda MR, Mudavath SL, Srivastava ON, Sundar S.

Nanomedicine (Lond). 2019 Jul;14(14):1911-1927. doi: 10.2217/nnm-2018-0448. Epub 2019 Jul 17.

PMID:
31313971
31.

Banning free speech is counterproductive.

Sundar S.

BMJ. 2019 Jul 16;366:l4626. doi: 10.1136/bmj.l4626. No abstract available.

PMID:
31311784
32.

Quality of life outcomes following surgery for advanced ovarian cancer: a systematic review and meta-analysis.

Kumar S, Long J, Kehoe S, Sundar S, Cummins C.

Int J Gynecol Cancer. 2019 Oct;29(8):1285-1291. doi: 10.1136/ijgc-2018-000125. Epub 2019 Jul 3.

PMID:
31273066
33.

Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Sundar S, Agrawal N, Singh B.

Expert Opin Drug Metab Toxicol. 2019 Jul;15(7):595-612. doi: 10.1080/17425255.2019.1629417. Epub 2019 Jun 17. Review.

PMID:
31174439
34.

Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.

Woods BS, Sideris E, Sydes MR, Gannon MR, Parmar MKB, Alzouebi M, Attard G, Birtle AJ, Brock S, Cathomas R, Chakraborti PR, Cook A, Cross WR, Dearnaley DP, Gale J, Gibbs S, Graham JD, Hughes R, Jones RJ, Laing R, Mason MD, Matheson D, McLaren DB, Millman R, O'Sullivan JM, Parikh O, Parker CC, Peedell C, Protheroe A, Ritchie AWS, Robinson A, Russell JM, Simms MS, Srihari NN, Srinivasan R, Staffurth JN, Sundar S, Thalmann GN, Tolan S, Tran ATH, Tsang D, Wagstaff J, James ND, Sculpher MJ.

Eur Urol Oncol. 2018 Dec;1(6):449-458. doi: 10.1016/j.euo.2018.06.004. Epub 2018 Sep 14.

35.

Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3).

NIHR Global Health Research Uniton Global Surgery.

BMJ Open. 2019 May 24;9(5):e026646. doi: 10.1136/bmjopen-2018-026646.

36.

Black women with postmenopausal bleeding have lower prevalence of endometrial cancer than other ethnic groups.

Ghoubara A, Sundar S, Ewies AAA.

Climacteric. 2019 Dec;22(6):632-636. doi: 10.1080/13697137.2019.1606794. Epub 2019 May 20.

PMID:
31104512
37.

Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani.

Veronica J, Chandrasekaran S, Dayakar A, Devender M, Prajapati VK, Sundar S, Maurya R.

FEBS J. 2019 Sep;286(17):3488-3503. doi: 10.1111/febs.14923. Epub 2019 Jun 1.

PMID:
31087522
38.

Current and emerging medications for the treatment of leishmaniasis.

Chakravarty J, Sundar S.

Expert Opin Pharmacother. 2019 Jul;20(10):1251-1265. doi: 10.1080/14656566.2019.1609940. Epub 2019 May 7. Review.

PMID:
31063412
39.

Refining wet lab experiments with in silico searches: A rational quest for diagnostic peptides in visceral leishmaniasis.

Bremer Hinckel BC, Marlais T, Airs S, Bhattacharyya T, Imamura H, Dujardin JC, El-Safi S, Singh OP, Sundar S, Falconar AK, Andersson B, Litvinov S, Miles MA, Mertens P.

PLoS Negl Trop Dis. 2019 May 6;13(5):e0007353. doi: 10.1371/journal.pntd.0007353. eCollection 2019 May.

40.

Characterization of Alzheimer conditions in MR images using volumetric and sagittal brainstem texture features.

Rohini P, Sundar S, Ramakrishnan S.

Comput Methods Programs Biomed. 2019 May;173:147-155. doi: 10.1016/j.cmpb.2019.03.003. Epub 2019 Mar 7.

PMID:
31046989
41.
42.

High sensitivity troponin assays: too much of a good thing.

Sundar S.

BMJ. 2019 Apr 16;365:l1640. doi: 10.1136/bmj.l1640. No abstract available.

PMID:
30992262
43.

Palliative care: relocation rather than rebranding is needed.

Sundar S.

BMJ. 2019 Apr 10;365:l1641. doi: 10.1136/bmj.l1641. No abstract available.

PMID:
30971413
44.

Human Papillomavirus Genome based Detection and Typing: A Holistic Molecular Approach.

Gautam A, Gedda MR, Rai M, Sundar S, Chakravarty J.

Curr Mol Med. 2019;19(4):237-246. doi: 10.2174/1566524019666190405120441.

PMID:
30950352
45.

Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.

Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, Chourasia A, Singh T, Sudarshan M, Singh AP, Singh B, Singh RP, Ostyn B, Fakiola M, Picado A, Menten J, Blackwell JM, Wilson ME, Sacks D, Boelaert M, Sundar S.

PLoS Negl Trop Dis. 2019 Mar 27;13(3):e0007216. doi: 10.1371/journal.pntd.0007216. eCollection 2019 Mar.

46.

Immunogenicity and Protective Efficacy of T-Cell Epitopes Derived From Potential Th1 Stimulatory Proteins of Leishmania (Leishmania) donovani.

Joshi S, Yadav NK, Rawat K, Kumar V, Ali R, Sahasrabuddhe AA, Siddiqi MI, Haq W, Sundar S, Dube A.

Front Immunol. 2019 Feb 28;10:288. doi: 10.3389/fimmu.2019.00288. eCollection 2019.

47.

Correction: Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma-experience of the BriTROC consortium.

Goranova T, Ennis D, Piskorz AM, Macintyre G, Lewsley LA, Stobo J, Wilson C, Kay D, Glasspool RM, Lockley M, Brockbank E, Montes A, Walther A, Sundar S, Edmondson R, Hall GD, Clamp A, Gourley C, Hall M, Fotopoulou C, Gabra H, Freeman S, Moore L, Jimenez-Linan M, Paul J, Brenton JD, McNeish IA; BriTROC investigators.

Br J Cancer. 2019 Apr;120(8):868. doi: 10.1038/s41416-019-0433-6.

48.

Renaming low risk cancers: honest engagement with patients is more important.

Sundar S.

BMJ. 2019 Feb 26;364:l840. doi: 10.1136/bmj.l840. No abstract available.

PMID:
30808719
49.

Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.

Chauhan SB, Faleiro R, Kumar R, Ng S, Singh B, Singh OP, Singh SS, Amante F, Rivera FL, Rai M, Chakravarty J, Sacks D, Nylen S, Sundar S, Engwerda C.

J Infect Dis. 2019 Jun 5;220(1):163-173. doi: 10.1093/infdis/jiz074.

PMID:
30796820
50.

Abnormal B-Cell Subset and Blimp-1-Mediated Humoral Responses Associated With Visceral Leishmaniasis Pathogenesis.

Singh B, Singh OP, Singh N, Singh SS, Sundar S.

Am J Trop Med Hyg. 2019 Apr;100(4):816-821. doi: 10.4269/ajtmh.18-0350.

PMID:
30793688

Supplemental Content

Loading ...
Support Center